CAR T Therapy With GCAR1 for Relapsed Alveolar Soft Part Sarcoma

Inclusion Criteria: * The patient must provide informed consent * Adequate organ function, defined as creatinine clearance \>30 ml/min and LVEF \>45% Exclusion Criteria: * Any active uncontrolled infection * Pregnancy or nursing * Anti-cancer therapy within 21 calendar days prior to the first dose of lymphodepleting chemotherapy. If subject has received anti-cancer therapy, they must have recovered adequately from the toxicity and/or complications from the intervention prior to starting therapy as per the discretion of the Qualified Investigator/Co-Investigator